These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 21896520)

  • 1. Alternatively activated macrophages and airway disease.
    Byers DE; Holtzman MJ
    Chest; 2011 Sep; 140(3):768-774. PubMed ID: 21896520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cells are the critical source of IL-4/IL-13 in a mouse model of allergic asthma.
    Oeser K; Maxeiner J; Symowski C; Stassen M; Voehringer D
    Allergy; 2015 Nov; 70(11):1440-9. PubMed ID: 26214396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune pathways for translating viral infection into chronic airway disease.
    Holtzman MJ; Byers DE; Benoit LA; Battaile JT; You Y; Agapov E; Park C; Grayson MH; Kim EY; Patel AC
    Adv Immunol; 2009; 102():245-76. PubMed ID: 19477323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergic airway disease is unaffected by the absence of IL-4Rα-dependent alternatively activated macrophages.
    Nieuwenhuizen NE; Kirstein F; Jayakumar J; Emedi B; Hurdayal R; Horsnell WG; Lopata AL; Brombacher F
    J Allergy Clin Immunol; 2012 Sep; 130(3):743-750.e8. PubMed ID: 22552110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA profiling reveals opposing expression patterns for miR-511 in alternatively and classically activated macrophages.
    Karo-Atar D; Itan M; Pasmanik-Chor M; Munitz A
    J Asthma; 2015; 52(6):545-53. PubMed ID: 25405361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of alternatively activated macrophages to allergic lung inflammation: a tale of mice and men.
    Dasgupta P; Keegan AD
    J Innate Immun; 2012; 4(5-6):478-88. PubMed ID: 22440980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emodin alleviates alternatively activated macrophage and asthmatic airway inflammation in a murine asthma model.
    Song YD; Li XZ; Wu YX; Shen Y; Liu FF; Gao PP; Sun L; Qian F
    Acta Pharmacol Sin; 2018 Aug; 39(8):1317-1325. PubMed ID: 29417945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide induces steroid-resistant exacerbations in a mouse model of allergic airway disease collectively through IL-13 and pulmonary macrophage activation.
    Hadjigol S; Netto KG; Maltby S; Tay HL; Nguyen TH; Hansbro NG; Eyers F; Hansbro PM; Yang M; Foster PS
    Clin Exp Allergy; 2020 Jan; 50(1):82-94. PubMed ID: 31579973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternatively activated macrophages engage in homotypic and heterotypic interactions through IL-4 and polyamine-induced E-cadherin/catenin complexes.
    Van den Bossche J; Bogaert P; van Hengel J; Guérin CJ; Berx G; Movahedi K; Van den Bergh R; Pereira-Fernandes A; Geuns JM; Pircher H; Dorny P; Grooten J; De Baetselier P; Van Ginderachter JA
    Blood; 2009 Nov; 114(21):4664-74. PubMed ID: 19726720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of pendrin as a common mediator for mucus production in bronchial asthma and chronic obstructive pulmonary disease.
    Nakao I; Kanaji S; Ohta S; Matsushita H; Arima K; Yuyama N; Yamaya M; Nakayama K; Kubo H; Watanabe M; Sagara H; Sugiyama K; Tanaka H; Toda S; Hayashi H; Inoue H; Hoshino T; Shiraki A; Inoue M; Suzuki K; Aizawa H; Okinami S; Nagai H; Hasegawa M; Fukuda T; Green ED; Izuhara K
    J Immunol; 2008 May; 180(9):6262-9. PubMed ID: 18424749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma.
    Pappas K; Papaioannou AI; Kostikas K; Tzanakis N
    Cytokine; 2013 Dec; 64(3):613-25. PubMed ID: 24084332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease.
    Kim EY; Battaile JT; Patel AC; You Y; Agapov E; Grayson MH; Benoit LA; Byers DE; Alevy Y; Tucker J; Swanson S; Tidwell R; Tyner JW; Morton JD; Castro M; Polineni D; Patterson GA; Schwendener RA; Allard JD; Peltz G; Holtzman MJ
    Nat Med; 2008 Jun; 14(6):633-40. PubMed ID: 18488036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking acute infection to chronic lung disease. The role of IL-33-expressing epithelial progenitor cells.
    Holtzman MJ; Byers DE; Brett JA; Patel AC; Agapov E; Jin X; Wu K
    Ann Am Thorac Soc; 2014 Dec; 11 Suppl 5(Suppl 5):S287-91. PubMed ID: 25525734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin requires activation in accessory cells to modulate T-cell responses in asthma and COPD.
    Knobloch J; Yakin Y; Körber S; Grensemann B; Bendella Z; Boyaci N; Gallert WJ; Yanik SD; Jungck D; Koch A
    Eur J Pharmacol; 2016 Oct; 788():294-305. PubMed ID: 27343379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of IL-4 receptor alpha on smooth muscle cells is not necessary for development of experimental allergic asthma.
    Kirstein F; Horsnell WG; Kuperman DA; Huang X; Erle DJ; Lopata AL; Brombacher F
    J Allergy Clin Immunol; 2010 Aug; 126(2):347-54. PubMed ID: 20579713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophages: Their role, activation and polarization in pulmonary diseases.
    Arora S; Dev K; Agarwal B; Das P; Syed MA
    Immunobiology; 2018; 223(4-5):383-396. PubMed ID: 29146235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated Activation of Lung Invariant NKT Cells Results in Chronic Obstructive Pulmonary Disease-Like Symptoms.
    Tsao CC; Tsao PN; Chen YG; Chuang YH
    PLoS One; 2016; 11(1):e0147710. PubMed ID: 26811900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Do Innate Immune Cells Contribute to Airway Remodeling in COPD Progression?
    Bu T; Wang LF; Yin YQ
    Int J Chron Obstruct Pulmon Dis; 2020; 15():107-116. PubMed ID: 32021149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of airway epithelial cell culture to unravel the pathogenesis and study treatment in obstructive airway diseases.
    Mertens TCJ; Karmouty-Quintana H; Taube C; Hiemstra PS
    Pulm Pharmacol Ther; 2017 Aug; 45():101-113. PubMed ID: 28502841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: insights from transgenic mice.
    Elias JA; Kang MJ; Crothers K; Homer R; Lee CG
    Proc Am Thorac Soc; 2006 Aug; 3(6):494-8. PubMed ID: 16921126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.